Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.
Kutle I, Polten R, Stalp JL, Hachenberg J, Todzey F, Hass R, Zimmermann K, von der Ohe J, von Kaisenberg C, Neubert L, Kamp JC, Schaudien D, Seyda AK, Hillemanns P, Klapdor R, Morgan MA, Schambach A. Kutle I, et al. Among authors: hillemanns p. Front Immunol. 2024 Dec 16;15:1485461. doi: 10.3389/fimmu.2024.1485461. eCollection 2024. Front Immunol. 2024. PMID: 39781381 Free PMC article.
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.
Hillemanns P, Zikan M, Forget F, Denys HG, Baurain JF, Rob L, Woelber L, Blecharz P, Bidzinski M, Chovanec J, Marmé F, Link T, Dannecker C, Rosholm A, Berg KCG, Oliveri RS, Lindemann K; VB C-02 investigators; VB C-02 study. Hillemanns P, et al. J Immunother Cancer. 2025 Jan 7;13(1):e010827. doi: 10.1136/jitc-2024-010827. J Immunother Cancer. 2025. PMID: 39773564 Free article. Clinical Trial.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Among authors: hillemanns p. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
Germline variants of homology-directed repair or mismatch repair genes in cervical cancer.
Kokemüller L, Ramachandran D, Schürmann P, Geffers R, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Müller F, Fasching PA, Luyten A, Häfner N, Hillemanns P, Dörk T. Kokemüller L, et al. Among authors: hillemanns p. Int J Cancer. 2025 Feb 15;156(4):700-710. doi: 10.1002/ijc.35221. Epub 2024 Oct 23. Int J Cancer. 2025. PMID: 39440754 Free PMC article.
Web-Based Development of Standard Operating Procedures and Midwifery Trainings at Ugandan Birth Clinic in the Framework of Implementing a Quality Improvement System for the MEWU-Midwife Exchange with Uganda.
Stubbe L, Philippeit A, Philippeit J, Kaukemüller L, Kruppa M, Sunder-Plassmann M, Ruppert A, Hillemanns P, Mugisha J, Klapdor R. Stubbe L, et al. Among authors: hillemanns p. Womens Health Rep (New Rochelle). 2024 Oct 7;5(1):775-784. doi: 10.1089/whr.2024.0068. eCollection 2024. Womens Health Rep (New Rochelle). 2024. PMID: 39439765
Comparative sequencing study of mismatch repair and homology-directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan.
Zheng Y, Vdovichenko N, Schürmann P, Ramachandran D, Geffers R, Speith LM, Bogdanova N, Enßen J, Dubrowinskaja N, Yugay T, Yessimsiitova ZB, Turmanov N, Hillemanns P, Dörk T. Zheng Y, et al. Among authors: hillemanns p. Int J Cancer. 2025 Feb 15;156(4):764-775. doi: 10.1002/ijc.35215. Epub 2024 Oct 14. Int J Cancer. 2025. PMID: 39400928 Free PMC article.
Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical Cancer.
Ramachandran D, Mao Q, Liao D, Kamal M, Schürmann P, Eisenblätter R, Geffers R, Balint B, Lecompte L, Servant N, Chérif LL, Lamy C, Baulande S, Legoix P, Le Tourneau C, Latouche A, Hillemanns P, Scholl S, Dörk T. Ramachandran D, et al. Among authors: hillemanns p. Mol Carcinog. 2025 Jan;64(1):14-24. doi: 10.1002/mc.23822. Epub 2024 Oct 1. Mol Carcinog. 2025. PMID: 39352309
Accuracy of GynTect® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study.
Hoyer H, Scheungraber C, Mehlhorn G, Hagemann I, Scherbring S, Wölber L, Petzold A, Wunsch K, Schmitz M, Hampl M, Böhmer G, Hillemanns P, Runnebaum IB, Dürst M. Hoyer H, et al. Among authors: hillemanns p. Cancers (Basel). 2024 Aug 30;16(17):3022. doi: 10.3390/cancers16173022. Cancers (Basel). 2024. PMID: 39272880 Free PMC article.
449 results